Ocriplasmin
id:
ocriplasmin-201-1916181
title:
Ocriplasmin
text:
Ocriplasmin, sold under the brand name Jetrea, is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. It is used for treatment of symptomatic vitreomacular adhesion, for which it received FDA approval on 17 October 2012. It works by dissolving the proteins that link the vitreous to the macula, resulting in posterior detachment of the vitreous from the retina.
brand slug:
wiki
category slug:
encyclopedia
description:
Recombinant protease with activity against fibronectin and laminin
original url:
https://en.wikipedia.org/wiki/Ocriplasmin
date created:
date modified:
2023-04-11T01:03:16Z
main entity:
{"identifier":"Q2212643","url":"https://www.wikidata.org/entity/Q2212643"}
image:
fields total:
13
integrity:
14